Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07633847 · ClinicalTrials.gov registry record
A Post Market Trial Assessing the Accuracy of Normal Mode Reading vs. ProScan Reading With the NaviCam SB System. This is a Comparison of Retrospectively Obtained Capsule Endoscopy Videos With a New AI Reading Tool; no New Interventions Will be Completed.
A clinical trial, sponsored by AnX Robotica.
- Not yet
- Registry status
- 92
- Enrollment target
NCT07633847 is a clinical trial that has not yet begun recruiting, run by AnX Robotica. The registered enrollment target is 92 participants.
The verdict
NCT07633847 has not yet begun recruiting, sponsored by AnX Robotica.
- NOT YET RECRUITING
- Registry status
- 92 participants
- Enrollment target
Study Summary
NaviCam ProScan is an artificial intelligent (AI) assisted reading tool designed to aid small bowel capsule endoscopy reviewers in decreasing the time to review capsule endoscopy images for adult patients in whom the capsule endoscopy images were obtained for suspected small bowel bleeding.
Interventions
- DEVICE Video capsule endoscopy
- OTHER Phase II = Data analysis by Independent Readers
- OTHER Phase III = Data Analysis by Expert Readers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2026-06-15 |
| Est. Completion | 2028-09-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07633847
The ClinicalTrials.gov registry entry for NCT07633847 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AnX Robotica, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Video capsule endoscopy is the first listed.
NCT07633847 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07633847 about?
NCT07633847 is a clinical study titled "A Post Market Trial Assessing the Accuracy of Normal Mode Reading vs. ProScan Reading With the NaviCam SB System. This is a Comparison of Retrospectively Obtained Capsule Endoscopy Videos With a New AI Reading Tool; no New Interventions Will be Completed.". NaviCam ProScan is an artificial intelligent (AI) assisted reading tool designed to aid small bowel capsule endoscopy reviewers in decreasing the time to review capsule endoscopy images for adult patients in whom the capsule endoscopy images were obtained for suspected small bowel bleeding.
What is the current status of trial NCT07633847?
This trial is currently not yet recruiting. The enrollment target is 92 participants. The study started on 2026-06-15. Estimated completion is 2028-09-15.
What interventions are being tested in trial NCT07633847?
The interventions under investigation include: Video capsule endoscopy (DEVICE), Phase II = Data analysis by Independent Readers (OTHER), Phase III = Data Analysis by Expert Readers (OTHER).
Who is sponsoring clinical trial NCT07633847?
This trial is sponsored by AnX Robotica, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.